The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Expression of Concern: Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double‐blind, placebo‐controlled trial
Abstract
Objective: This study was performed to determine the effects of probiotic supplementation on clinical and metabolic status of patients with rheumatoid arthritis (RA). Methods: Sixty patients with RA aged 25–70 years were assigned into two groups to receive either probiotic capsules (n = 30) or placebo (n = 30) in this randomized, double‐blind, placebo‐controlled trial. The patients in the probiotic group received a daily capsule that contained three viable and freeze‐dried strains: Lactobacillus acidophilus (2 × 10 9 colony‐forming units [CFU]/g), Lactobacillus casei (2 × 10 9 CFU/g) and Bifidobacterium bifidum (2 × 10 9 CFU/g) for 8 weeks. The placebo group took capsules filled with cellulose for the same time period. Fasting blood samples were taken at the beginning and the end of the study to quantify related markers. Results: After 8 weeks of intervention, compared with the placebo, probiotic supplementation resulted in improved Disease Activity Score of 28 joints (DAS‐28) (−0.3 ± 0.4 vs. −0.1 ± 0.4, P = 0.01). In addition, a significant decrease in serum insulin levels (−2.0 ± 4.3 vs. +0.5 ± 4.9 μ IU/mL, P = 0.03), homeostatic model assessment‐B cell function (HOMA‐B) (−7.5 ± 18.0 vs. +4.3 ± 25.0, P = 0.03) and serum high‐sensitivity C‐reactive protein (hs‐CRP) concentrations (−6.66 ± 2.56 vs. +3.07 ± 5.53 mg/L, P < 0.001) following the supplementation of probiotics compared with the placebo. Subjects who received probiotic capsules experienced borderline statistically significant improvement in total‐ (P = 0.09) and low‐density lipoprotein‐cholesterol levels (P = 0.07) compared with the placebo. Conclusion: Overall, the results of this study indicated that taking probiotic supplements for 8 weeks among patients with RA had beneficial effects on DAS‐28, insulin levels, HOMA‐B and hs‐CRP levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M. R., Asemi, Z., & Esmaillzadeh, A. (2016) · Nutrition · doi:10.1016/j.nut.2015.09.003 · Cited by 767
Self-citationBeneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion
Yadav, H., Lee, J.-H., Lloyd, J., Walter, P., & Rane, S. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.452516 · Cited by 709
Limitations in the Use of Indices Using Glucose and Insulin Levels to Predict Insulin Sensitivity
Pisprasert, V., Ingram, K. H., Lopez-Davila, M. F., Munoz, A. J., & Garvey, W. T. (2013) · Diabetes Care · doi:10.2337/dc12-0840 · Cited by 302
Vaghef-Mehrabany, E., Homayouni-Rad, A., Alipour, B., Sharif, S.-K., Vaghef-Mehrabany, L., & Alipour-Ajiry, S. (2016) · Journal of the American College of Nutrition · doi:10.1080/07315724.2014.959208 · Cited by 88
Cited by
The role of the gut microbiome in systemic inflammatory disease
Clemente, J. C., Manasson, J., & Scher, J. U. (2018) · BMJ · doi:10.1136/bmj.j5145 · Cited by 568
Intestinal Lactobacillus in health and disease, a driver or just along for the ride?
Heeney, D. D., Gareau, M. G., & Marco, M. L. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.08.004 · Cited by 369
Encapsulation of probiotics and nutraceuticals: Applications in functional food industry
Reque, P. M., & Brandelli, A. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.05.022 · Cited by 336
Intestinal dysbiosis and probiotic applications in autoimmune diseases
de Oliveira, G. L. V., Leite, A. Z., Higuchi, B. S., Gonzaga, M. I., & Mariano, V. S. (2017) · Immunology · doi:10.1111/imm.12765 · Cited by 322
The Gut Microbiota and Respiratory Diseases: New Evidence
Chunxi, L., Haiyue, L., Yanxia, L., Jianbing, P., & Jin, S. (2020) · Journal of Immunology Research · doi:10.1155/2020/2340670 · Cited by 264
Metadata
- Authors
- Zamani, B., Golkar, H. R., Farshbaf, S., Emadi‐Baygi, M., Tajabadi‐Ebrahimi, M., Jafari, P., Akhavan, R., Taghizadeh, M., Memarzadeh, M. R., & Asemi, Z.
- Venue
- International Journal of Rheumatic Diseases
- Publisher
- Wiley
- Published
- 2016-05-02
- Volume
- 19
- Issue
- 9
- Pages
- 869-879
- ISSN
- 1756-1841 (ISSN-L)
- 1756-185X
- OpenAlex
- W2345975446
- Cited by
- 218
- References
- 4
- FWCI
- 19.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Expression of Concern: Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double‐blind, placebo‐controlled trial. https://app.cochat.ai/papers/10.1111/1756-185x.12888
- The paper
- Zamani, B., Golkar, H. R., Farshbaf, S., Emadi‐Baygi, M., Tajabadi‐Ebrahimi, M., Jafari, P., Akhavan, R., Taghizadeh, M., Memarzadeh, M. R., & Asemi, Z. (2016). Expression of Concern: Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double‐blind, placebo‐controlled trial. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.12888
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.